Company: BACC
Filing Date: 2025-03-26
Form Type: DRS
Source: 0001185185-25-000217
Chunk: 18

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-03-26
Form: DRS
Chunk 18
---
.004 per underlying 
 founder share to the non-managing sponsor investors at the closing of this offering reflecting   
 indirect interests in an aggregate of 3,271,739 founder shares (or 3,762,500 founder             
 shares if the underwriters exercise the over-allotment option in full) held by the sponsor.      
 Up to 790,425 of the founder shares will be surrendered for no consideration depending on        
 the extent to which the underwriters’ over-allotment option is not exercised.                    |

<div align='center'>5</div>

| (2) | The                                                                                          
 non-managing sponsor investors have expressed an interest to purchase, indirectly through    
 the purchase of non-managing membership interests, an aggregate of 365,000 private placement 
 units (or 376,250 private placement units if the over-allotment is exercised in full) at     
 a price of $10.00 per unit ($3,650,000 in the aggregate, or $3,762,500 of the over-allotment 
 option is exercised in full) in a private placement that will close simultaneously with the  
 closing of this offering. The purchase of the non-managing sponsor membership interests is   
 not contingent upon the participation in this offering or vice versa.                        |
| (3) | As of the date of this prospectus, no such arrangements are currently                        
 in place.                                                                                    |

Because our sponsor acquired the founder shares at a nominal price of $0.004 per share, our public shareholders will incur immediate and material dilution upon the closing of this offering. Further, the Class A ordinary shares issuable in connection with the conversion of the founder shares may result in material dilution to our public shareholders due to the anti-dilution rights of our founder shares that may result in an issuance of Class A ordinary shares on a greater than one-for-one basis upon conversion. Additionally, our public shareholders may experience dilution from the conversion of the 565,000 private placement rights into 56,500 Class A ordinary shares (or 621,250 private placement rights converting into 62,125 Class A ordinary shares if the underwriters’ over-allotment option is exercised in full) to be purchased in the private placement simultaneously with the closing of this offering. Further, our public shareholders may experience material dilution if the $1,500,000 in working capital loans is fully advanced by the sponsor and the sponsor elects to convert the working capital loans into private placement units at $10.00 per unit